Immune evasive human islet-like organoids ameliorate diabetes

While stem cell-derived islets hold promise as a therapy for insulin-dependent diabetes, challenges remain in achieving this goal(1–6). Here we generate human islet-like organoids (HILOs) from induced pluripotent stem cells (iPSCs) and show that non-canonical WNT4 signaling drives the metabolic matu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshihara, Eiji, O’Connor, Carolyn, Gasser, Emanuel, Wei, Zong, Oh, Tae Gyu, Tseng, Tiffany W., Wang, Dan, Cayabyab, Fritz, Dai, Yang, Yu, Ruth T., Liddle, Christopher, Atkins, Annette R., Downes, Michael, Evans, Ronald M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872080/
https://www.ncbi.nlm.nih.gov/pubmed/32814902
http://dx.doi.org/10.1038/s41586-020-2631-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872080/
https://www.ncbi.nlm.nih.gov/pubmed/32814902
http://dx.doi.org/10.1038/s41586-020-2631-z

Ejemplares similares